Dyne Therapeutics Stock Market Value
| DYN Stock | USD 29.69 0.04 0.13% |
| Symbol | Dyne |
Dyne Therapeutics Price To Book Ratio
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Dyne Therapeutics. If investors know Dyne will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Dyne Therapeutics listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (3.58) | Return On Assets (0.40) | Return On Equity (0.69) |
The market value of Dyne Therapeutics is measured differently than its book value, which is the value of Dyne that is recorded on the company's balance sheet. Investors also form their own opinion of Dyne Therapeutics' value that differs from its market value or its book value, called intrinsic value, which is Dyne Therapeutics' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Dyne Therapeutics' market value can be influenced by many factors that don't directly affect Dyne Therapeutics' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Dyne Therapeutics' value and its price as these two are different measures arrived at by different means. Investors typically determine if Dyne Therapeutics is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Dyne Therapeutics' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
Dyne Therapeutics 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Dyne Therapeutics' stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Dyne Therapeutics.
| 12/06/2022 |
| 11/25/2024 |
If you would invest 0.00 in Dyne Therapeutics on December 6, 2022 and sell it all today you would earn a total of 0.00 from holding Dyne Therapeutics or generate 0.0% return on investment in Dyne Therapeutics over 720 days. Dyne Therapeutics is related to or competes with Stoke Therapeutics, Pliant Therapeutics, Cytokinetics, Revolution Medicines, Edgewise Therapeutics, Cullinan Oncology, and Mineralys Therapeutics,. Dyne Therapeutics, Inc., a muscle disease company, operates as a biotechnology company that focuses on advancing therape... More
Dyne Therapeutics Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Dyne Therapeutics' stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Dyne Therapeutics upside and downside potential and time the market with a certain degree of confidence.
| Information Ratio | (0.12) | |||
| Maximum Drawdown | 32.99 | |||
| Value At Risk | (5.63) | |||
| Potential Upside | 5.7 |
Dyne Therapeutics Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for Dyne Therapeutics' investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Dyne Therapeutics' standard deviation. In reality, there are many statistical measures that can use Dyne Therapeutics historical prices to predict the future Dyne Therapeutics' volatility.| Risk Adjusted Performance | (0.06) | |||
| Jensen Alpha | (0.80) | |||
| Total Risk Alpha | (1.34) | |||
| Treynor Ratio | (0.20) |
Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Dyne Therapeutics' price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Dyne Therapeutics Backtested Returns
Dyne Therapeutics secures Sharpe Ratio (or Efficiency) of -0.0837, which denotes the company had a -0.0837% return per unit of risk over the last 3 months. Dyne Therapeutics exposes twenty-four different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please confirm Dyne Therapeutics' Standard Deviation of 5.35, variance of 28.61, and Mean Deviation of 3.1 to check the risk estimate we provide. The firm shows a Beta (market volatility) of 2.52, which means a somewhat significant risk relative to the market. As the market goes up, the company is expected to outperform it. However, if the market returns are negative, Dyne Therapeutics will likely underperform. At this point, Dyne Therapeutics has a negative expected return of -0.45%. Please make sure to confirm Dyne Therapeutics' potential upside, as well as the relationship between the rate of daily change and period momentum indicator , to decide if Dyne Therapeutics performance from the past will be repeated at some point in the near future.
Auto-correlation | -0.36 |
Poor reverse predictability
Dyne Therapeutics has poor reverse predictability. Overlapping area represents the amount of predictability between Dyne Therapeutics time series from 6th of December 2022 to 1st of December 2023 and 1st of December 2023 to 25th of November 2024. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Dyne Therapeutics price movement. The serial correlation of -0.36 indicates that just about 36.0% of current Dyne Therapeutics price fluctuation can be explain by its past prices.
| Correlation Coefficient | -0.36 | |
| Spearman Rank Test | -0.62 | |
| Residual Average | 0.0 | |
| Price Variance | 78.92 |
Dyne Therapeutics lagged returns against current returns
Autocorrelation, which is Dyne Therapeutics stock's lagged correlation, explains the relationship between observations of its time series of returns over different periods of time. The observations are said to be independent if autocorrelation is zero. Autocorrelation is calculated as a function of mean and variance and can have practical application in predicting Dyne Therapeutics' stock expected returns. We can calculate the autocorrelation of Dyne Therapeutics returns to help us make a trade decision. For example, suppose you find that Dyne Therapeutics has exhibited high autocorrelation historically, and you observe that the stock is moving up for the past few days. In that case, you can expect the price movement to match the lagging time series.
Current and Lagged Values |
| Timeline |
Dyne Therapeutics regressed lagged prices vs. current prices
Serial correlation can be approximated by using the Durbin-Watson (DW) test. The correlation can be either positive or negative. If Dyne Therapeutics stock is displaying a positive serial correlation, investors will expect a positive pattern to continue. However, if Dyne Therapeutics stock is observed to have a negative serial correlation, investors will generally project negative sentiment on having a locked-in long position in Dyne Therapeutics stock over time.
Current vs Lagged Prices |
| Timeline |
Dyne Therapeutics Lagged Returns
When evaluating Dyne Therapeutics' market value, investors can use the concept of autocorrelation to see how much of an impact past prices of Dyne Therapeutics stock have on its future price. Dyne Therapeutics autocorrelation represents the degree of similarity between a given time horizon and a lagged version of the same horizon over the previous time interval. In other words, Dyne Therapeutics autocorrelation shows the relationship between Dyne Therapeutics stock current value and its past values and can show if there is a momentum factor associated with investing in Dyne Therapeutics.
Regressed Prices |
| Timeline |
Pair Trading with Dyne Therapeutics
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Dyne Therapeutics position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Dyne Therapeutics will appreciate offsetting losses from the drop in the long position's value.Moving together with Dyne Stock
Moving against Dyne Stock
| 0.5 | NXGLW | NexGel Warrant | PairCorr |
| 0.38 | MLYS | Mineralys Therapeutics, | PairCorr |
| 0.34 | KZR | Kezar Life Sciences | PairCorr |
| 0.33 | MDGL | Madrigal Pharmaceuticals | PairCorr |
| 0.33 | RNXT | RenovoRx | PairCorr |
The ability to find closely correlated positions to Dyne Therapeutics could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Dyne Therapeutics when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Dyne Therapeutics - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Dyne Therapeutics to buy it.
The correlation of Dyne Therapeutics is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Dyne Therapeutics moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Dyne Therapeutics moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Dyne Therapeutics can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Check out Dyne Therapeutics Correlation, Dyne Therapeutics Volatility and Dyne Therapeutics Alpha and Beta module to complement your research on Dyne Therapeutics. To learn how to invest in Dyne Stock, please use our How to Invest in Dyne Therapeutics guide.You can also try the Portfolio Suggestion module to get suggestions outside of your existing asset allocation including your own model portfolios.
Dyne Therapeutics technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.